Digital marketing for life sciences: how to build a system buyers trust

95% of B2B marketers expect significant sales within two weeks of a campaign. About 5% of buyers are in-market. Digital marketing for life sciences starts by closing that gap.

________________________________________________________________________________________________________________

Your board wants pipeline by March. Sales wants more leads. The scientists want every claim exact. All three expect results within weeks.

That expectation is the first problem. Life science buyers take months to decide, consult several departments, and form a view of you before your first email lands.

This guide sets out how we run digital marketing for life science, medtech, diagnostics and lab equipment companies. It covers what the work is, how it differs from general B2B marketing, and which channels reach buyers. It then shows how to build the strategy, what the first 90 days look like and how to measure results. It closes with the mistakes that cost teams the most time.

The method comes from seven years of work with scale-ups that sell to labs, hospitals and pharma. Where a figure is ours, we say so, and where it comes from outside research, we link the source.

What is digital marketing for life sciences?

Digital marketing for life sciences gets scientists, clinicians and procurement teams to know your name before they need you. It then wins the conversation when they do need you, using application notes, webinars, search, LinkedIn, email and events. Qualified conversations and pipeline are the score.

Two parts carry the definition. The first is content that answers real buyer questions: application notes on an assay or workflow, white papers, webinars, case studies and plain explainers. The second is distribution to a narrow audience across Google, AI search, LinkedIn, email, trade media and conferences.

We build it in layers. Positioning, messaging and buyer personas sit at the base, content comes next, and search and AI search make that content findable. Ads, PR and outbound campaigns add reach on top, and each layer depends on the one below. Running Google Ads before the landing pages, analytics and CRM exist sends every lead into a gap.

The sales pipeline defines the finish line. Marketing that stops at a lead stops too early. We count the work done when a qualified buyer is in conversation with sales, and we judge it again when the deal closes.

How does it differ from general B2B marketing?

Digital marketing for life sciences differs from general B2B marketing in four ways: small markets, buying groups, risk-averse buyers and long cycles. Regulated claims add a fifth constraint for medtech and diagnostics.

Small markets

A country with 100 digital PCR labs and three decision makers per lab holds 300 buyers, and a cold email blast spends the whole market in a week. A few recipients reply, while most remember a stranger who skipped the introduction. Treat each contact as a limited resource, and earn the second touch with something useful. Three hundred buyers is a short list.

Buying groups

Forrester's State of Business Buying 2026 puts the average purchase at 13 internal stakeholders and 9 external participants. Gartner counts 6 to 10 decision makers on a complex purchase and finds that buyers spend about 17% of buying time meeting suppliers. Definitions differ, but the direction does not.

In clinical settings the group has its own politics. In one hospital remote-monitoring rollout, oncology nurses were funded through a separate programme and reported to a nursing director, so a physician's endorsement did not move them. The Edelman-LinkedIn 2025 report finds that over 40% of B2B deals stall on misalignment inside the buying group. Write for the nurse as well as the physician.

One message cannot do four jobs, because champions, users, decision makers and blockers each need a different answer. We cover the roles in our guide to US medtech positioning.

Risk-averse buyers

Cell therapy developers work to remove unpredictability from manufacturing, and competitors exploit that by calling a new all-in-one platform risky. The marketing job is to build trust with scientists and executives alike before the first sales call, using data, named experts and customer proof.

Long cycles

Research from 2021 by Professor John Dawes of the Ehrenberg-Bass Institute, working with LinkedIn's B2B Institute, finds that only about 5% of B2B buyers are in-market at any time. The same programme found that 95% of B2B marketers expected significant sales within two weeks of a campaign (Marketing Week).

6sense reports in 2025 that 94% of buying groups rank their preferred vendors before first contact. Marketing that waits for a request arrives after the shortlist closes. Be known before the need appears.

Regulated claims

In medtech and diagnostics, advertising falls under Article 7 of the EU MDR and IVDR. It prohibits text and images that mislead users about a device's intended purpose, safety or performance (IVDR text). Marketing copy counts as a claim. Every claim needs evidence on file before it ships, and your regulatory team signs off. This section is not legal advice.

Which channels reach life science buyers?

Life science buyers are reached through owned content, search, LinkedIn, webinars, events and outbound. One rule ties them together: choose a narrow segment, then appear everywhere in it.

Segment first, then saturate

A biologics tools company chose a single drug modality as its first segment, and we wrote email, ads and content only for the formulation engineers working on it. Coverage inside a small segment beats thin coverage of a large market. A medtech company can apply the same rule to one clinical specialty.

Website and Google

Biocompare's 2025 antibody report finds that many scientists start their search on Google, not on vendor websites. It also finds that brand familiarity and product transparency now weigh more than they did in 2022. Write pages that name the assay and the application, show the validation data and put the question in the title. Google comes first.

AI search

AI tools now sit inside research. 6sense reports in 2025 that 94% of B2B buyers use large language models during a purchase, mainly to synthesise information. A BioInformatics survey of 408 life scientists in April 2025 found that 87% use AI at work, and half hold at least one negative association such as mistrust. Buyers use AI, then check the result.

Engines cite third-party sources more than company websites, so directories, trade press and bylined LinkedIn articles carry weight. Old content hurts. For an orthotics software client we cut 105 blogs to 43 and ungated 27 assets. The site then ranked first for four niche keywords it had not ranked for before. Volumes on those terms are low, but buyers who search them are close to choosing.

Structure moves the number too: title tags, entity schema and a copy rewrite took a CDMO from 21% to 44% AI visibility in seven weeks. It stood at 38% after six months. Our AI search visibility guide covers the method.

LinkedIn

Agency studies, including Refine Labs, find that personal profiles earn about five times the engagement of a company page. Put your scientists' names on long-form posts about an assay, a protocol or a clinical result, and use the company page as the place buyers land once they know you. Two to three posts a week is enough. Ask experts to repost, and expect a minority to do it. People outrank logos.

Webinars

Scientists and lab heads commit to a webinar or its recording because it puts faces in front of a company. Run each webinar in five steps:

1. Six weeks out: build the LinkedIn event, the registration page and the title.
2. On the day: a client expert hosts, with two or three questions ready for the silence after the talk.
3. Same day: send the recording.
4. Within three days: follow up personally with every hand-raiser.
5. After the edit: publish on YouTube with a transcript, and cut clips for ads.

ON24's 2026 benchmarks put registration-to-attendance at 60% and show 43% of attendees watching on demand, but that is platform data. Our own life science webinars see 30% to 35% of registrants attend. Plan for the lower number, and run them in September and October, before labs set next year's budgets. Our webinar lead generation guide sets the format in full.

Events

We work on the weeks before and after a conference, not the booth. A month ahead, connect on LinkedIn with last year's attendees, then post three times: two months out, one week out and the day before. After the show, ungate the poster within days and turn it into an article. Ask each scientist for a two-minute voice note within 72 hours covering the takeaway, the expectation and the questions asked at the poster. A voice note takes two minutes.

Email and outbound

Outbound works when the list is small, accurate and specific. Data work comes first: the right labs, the right people, and the assays and instruments each lab runs. AI writes the first draft of each message and a person edits it, which takes about a third of the time it took a few years ago. Review-based personalisation earned a 24% cold email reply rate against a 3% to 8.5% benchmark in our own work (AI and learning speed guide). Send from one named mailbox and route replies to one person.

Paid media

Keep paid media light before launch, and retarget people who already know you. Expect LinkedIn leads to cost more than most plans assume. In week two of a campaign for a European life science company, about €700 of spend produced five leads. Our ChatGPT ads guide covers the newest paid channel.

How do you build a strategy?

A digital marketing strategy for life sciences follows five moves: assess maturity, define the strategy, write the messaging playbook, pick beachheads, then plan channels and the sales handoff.

1. Assess maturity. Check the landing pages, analytics and CRM before you buy traffic, because leads sent to a site that cannot capture them are lost. A weak stack needs foundations first.
2. Define the strategy before the tactics. Teams name channels first, such as LinkedIn ads or a TikTok test. Ask for the commercial goal, the segment and the plan, then choose channels.
3. Write the messaging playbook. Interview customers, build ideal customer profiles and buyer personas, and write messages per persona and per application. Review them every six months as the field gives feedback. Start with one application, then bring the work back up to company level.
4. Pick two or three beachheads. When a client says the market is everyone, we ask for two or three segments first. Find labs inside them, collect testimonials and build from there.
5. Plan the channels and the handoff. Agree when sales receives a lead, at first interaction or after several, and pass it into the CRM with its full history. Run a feedback loop from sales inside every campaign: which campaigns work, what the field hears and what competitors do.

PhD-level scientists interview your experts and write the first draft, so your team reviews instead of explaining.

Start the CRM early. A company that launches commercially in two years needs an owned contact list by then, and a list takes time to build. HubSpot is our default build, and we are a HubSpot partner. Any CRM works when it is set up well.

One trade-off stays open. A pilot on one service delivers a quick win, but the cost shows up later, when a second service needs its own messaging and the work restarts. We agree to a pilot when proof matters most, and we write that service's playbook first. Our launch strategy case study shows the sequence at work.

What does the first 90 days look like?

The first 90 days of a digital marketing programme build foundations and run one campaign. Days 1 to 30 produce a messaging playbook and fixed analytics. Days 31 to 60 produce core assets and a campaign landing page. Days 61 to 90 launch a targeted campaign. Results arrive after that.

Systems take three, six or nine months to produce steady leads, so set leading indicators first: rankings, traffic on high-intent keywords, reply rates and registrants who match your profile. Form fills and booked conversations follow, and by month nine the new articles rank and drive traffic.

Do not wait for January, because a plan that starts in January reaches full speed at the end of the first quarter. Most of our lab clients set next year's budgets in autumn, so September and October suit webinars and launch pushes.

How do you measure it?

Measure a digital marketing programme on qualified conversations first, organic growth second and AI visibility on a fixed set of buyer prompts. Review each channel weekly, and count a lead as qualified only when sales logs an opportunity.

• Organic growth. Count visitors on high-intent keywords, time on page, then contact and demo requests, and compare against the same period last year.
• Webinars. Track registrants, the share that match your ideal customer profile and page visits to the recording and transcript.
• Qualified leads. Call a lead qualified when sales follows up, finds an opportunity and enters a value in the CRM.
• Source of lead. Add a "where did you hear about us" field to the contact form only, and keep content forms to name, company and email.
• AI visibility. Run the same 18 buyer prompts monthly across four AI tools, three times each, with six prompts for awareness, six for consideration and six for decision. Swings between months are normal. AI tools add UTM parameters when they link to you, so form submissions trace back to them. You cannot count how many times an answer names you, so use a query-testing tool as a proxy.

Run a weekly readout per channel covering connections accepted, emails sent and delivered, cost per lead, landing page conversion and nurture clicks. A click rate above 3% is the floor we hold, and 7% is strong.

Use the right denominator. A dedicated landing page converts at a median of 6.6% across industries in Unbounce's Q4 2024 data (summary). A content-hub page with many casual views converts far lower.

Which mistakes cost the most time?

The seven costliest mistakes in digital marketing for life sciences start with expecting leads in weeks, positioning wide and blasting a small market. They continue with one-off webinars, stale or gated content, pages that block action and leads that never reach the CRM.

1. Expecting leads in weeks. Cycles run in months. Most of your market is not buying yet.
2. Positioning wide. A contract research organisation with a long list of services drew mostly branded searches and scattered requests. A specialist looks like an expert even when the generalist has more capability.
3. Blasting a small market. For a European life science company, about 1,200 emails reached inboxes at 100% deliverability and drew no replies, so we paused the next wave and rewrote the pitch.
4. Treating a webinar as a one-off. One webinar gives one touchpoint. Buyers need several before they act.
5. Leaving stale or gated content live. Old posts confuse AI search. Gated files give crawlers nothing to read.
6. Pages and forms that block action. A CDMO's white paper page showed a download button that was only a graphic, and average engagement on it ran 2 seconds against 54 seconds on an article. Ask for name, company and email on low-commitment assets.
7. Leads that never reach the CRM. A relevant lead from an ad never appeared in a European life science company's contact list or nurture flow. Check that every form feeds the CRM and the workflow before launch.

FAQ

What are the best life sciences marketing tips?

Segment narrowly, then cover that segment on every channel, and check your CRM, analytics and landing pages before you buy traffic. Start from one application and one playbook, and put experts' names on content. Judge results on qualified conversations, not impressions, and give the system three to nine months.

How do you plan a life sciences marketing campaign?

Set one goal and one audience, then audit the content you hold and list the gaps. Plan distribution from cold audiences to warm ones and set KPIs for each layer. Build a campaign landing page, one core asset and an outbound sequence, and add a webinar as the high point.

What goals should a life sciences marketing strategy set?

Set commercial goals first: qualified conversations, pipeline and revenue. Support them with leading indicators such as organic traffic on high-intent keywords, registrants who match your ideal profile and reply rates. Agree the definition of a qualified lead with sales before launch.

How should science companies approach marketing?

Run it as a system, staffed by people who understand the science. Interview your experts, write the content first time right and distribute it on purpose. Pair scientists with marketers so a PhD and a campaign builder sit in the same room.

Which life sciences marketing strategies work?

Strategies that build trust with the whole buying group work: reach, credibility and influence. Reach builds awareness in your segment, credibility comes from named experts and data, and influence comes from an owned contact list of people who know you.

Build the system before you buy the traffic

A market of 300 buyers gives you one clean first impression. Spend it on something worth reading. Start with one segment, one playbook and one campaign.

Send us your top five buyer questions. We run them across four AI tools, check your channel mix against the seven mistakes above, and return the first three fixes. Contact us to start.

Sources

• Forrester, State of Business Buying 2026 (summary)
• Edelman and LinkedIn, 2025 B2B Thought Leadership Impact Report
• Weinberg and Lombardo, The 95:5 rule, Marketing Week
• 6sense, 2025 Buyer Experience Report (press release)
• Biocompare, 2025 Antibody Market Report
• BioInformatics, AI in life science labs, 2026
• Refine Labs, Employee profiles outperform brand pages on LinkedIn
• ON24, 2026 webinar benchmarks
• Unbounce landing page benchmarks (summary)
• EU IVDR Article 7 text
• Gartner, B2B buying journey research

Client examples are anonymised.